SCHEMBL28548876

SCHEMBL28548876

CCOC(=O)c1cc(OC)c2nc(Cl)sc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.47
ALDH1A1 P00352 7/20 0.46
HTT P42858 1/20 0.43
HPGD P15428 4/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 3/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
STAT1 P42224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9951657 0.87 ALDH1A1 (0.50) ALDH1A1HTTHPGDSMN1; SMN2LMNA
SCHEMBL28548830 0.83 RAB9A (0.45) ALDH1A1HTTHPGDNPC1RAB9A
SCHEMBL20554083 0.82 ALDH1A1 (0.51) ALDH1A1HTTCA12CA1CA2
SCHEMBL20554293 0.82 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL1458301 0.76 HSD17B2 (0.61) HSD17B2ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL18031363 0.75 HSD17B2 (0.51) HSD17B2ALDH1A1HTTNPC1RAB9A
SCHEMBL1094691 0.75 NPC1 (0.65) ALDH1A1HTTHPGDNPC1RAB9A
SCHEMBL23904824 0.74 HSD17B2 (0.47) HSD17B2HTTNPC1RAB9AKMT2A
SCHEMBL20094718 0.74 RAB9A (0.48) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9952440 0.74 KDM4E (0.42) ALDH1A1HTTHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108341822-B FXR receptor modulator and preparation method and application thereof 广州市恒诺康医药科技有限公司 2021-04-16 CN disclosed